Eisai
4523.T
$43.90
Share price
-5.19%
Change (1 day)
-34.34%
Change (1 year)
Categories
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.
Earnings for Eisai (4523.T)
Earnings in 2024 (TTM): NZ$0.72 Billion
According to Eisai's latest financial reports the company's current earnings are NZ$5.06 Billion. In 2023 the company made an earning of NZ$0.94 Billion, an increase over its 2022 earnings that were of -NZ$41.21 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Eisai from 2009 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024 (TTM)  | NZ$0.72 B | -23.6% |
| 2023 | NZ$0.94 B | -2392.87% |
| 2022 | -NZ$41.21 Million | -103.6% |
| 2021 | NZ$1.14 B | -39.52% |
| 2020 | NZ$1.89 B | 7.3% |
| 2019 | NZ$1.76 B | 17.23% |
| 2018 | NZ$1.50 B | 86.06% |
| 2017 | NZ$0.80 B | -23.64% |
| 2016 | NZ$1.05 B | 27.28% |
| 2015 | NZ$0.83 B | 22.08% |
| 2014 | NZ$0.68 B | -46.11% |
| 2013 | NZ$1.26 B | -21.67% |
| 2012 | NZ$1.61 B | -20.72% |
| 2011 | NZ$2.03 B | -8.44% |
| 2010 | NZ$2.22 B | 18.85% |
| 2009 | NZ$1.87 B |